argenx SE reported $7.18B in Assets for its fiscal quarter ending in June of 2025.





Assets Change Date
AstraZeneca USD 114.07B 382M Dec/2025
Galapagos EUR 3.41B 105.39M Dec/2025
Genmab DKK 12.87B 5.85B Dec/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
GRIFOLS EUR 19.71B 141.77M Dec/2025
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Qiagen NV USD 6.3B 257.54M Dec/2025
UCB EUR 18.16B 971M Dec/2025